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Aim. We hypothesized that 4 days of normal daily activity after 21 days of experimental bed rest (BR) will not reverse BR induced
impaired glucose tolerance. Design. Glucose tolerance of seven male, healthy, untrained test subjects (age: 27.6 (3.3) years (mean
(SD)); body mass: 78.6 (6.4) kg; height: 1.81 (0.04)m; VO
2
max: 39.5 (5.4)ml/kg body mass/min) was studied. They stayed twice
in the metabolic ward (crossover design), 21 days in bed and 7 days before and after BR each. Oral glucose tolerance tests were
applied before, on day 21 of BR, and 5 and 14 days after BR. Results. On day 21 of BR, AUC
120min of glucose concentration was
increased by 28.8 (5.2)% and AUC
120min of insulin by 35.9 (10.2)% (glucose: 𝑃 < 0.001; insulin: 𝑃 = 0.02). Fourteen days after BR,
AUC
120min of serum insulin concentrations returned to pre-bed-rest concentrations (𝑃 = 0.352) and AUC120min of glucose was still
higher (𝑃 = 0.038). Insulin resistance did not change, but sensitivity index was reduced during BR (𝑃 = 0.005). Conclusion. Four
days of light physical workload does not compensate inactivity induced impaired glucose tolerance. An individually tailored and
intensified training regime is mandatory in patients being in bed rest to get back to normal glucose metabolism in a reasonable
time frame.
1. Introduction
Exercise is one of the very promising measures to reduce
blood glucose concentrations potentially by enhancing
insulin-mediated glucose uptake [1]. On the other hand,
physical inactivity promotes high blood pressure, decreases
insulin sensitivity and muscle mass and strength, and sup-
ports obesity. Thereby, even 3 days of bed rest is sufficient
in healthy subjects to induce impaired glucose tolerance
following an oral glucose tolerance test (OGTT) [2–5]. But
not only extreme inactivity like bed rest induces impaired
glucose tolerance in young healthy people. Thyfault and
Booth summarized recently that “decreased frequency of
breaks from sitting, as well as longer total duration of
daily sitting, acutely lowers insulin sensitivity which would
chronically increase metabolic risk” [6], which is supported
by recent surveys in USA [7] and Australia [8].
But more and more people in the western world, even
young people, live a rather sedentary life style. Data derived
from the 2003-2004 National Health and Nutritional Exam-
ination survey (NHANES) demonstrate that only 8% of
adolescents (12–19 years) and less than 5% of adults (≥20
years) follow the recommendation of 30 to 60min of exercise
per day [9]. Taken into account that skeletal muscle loss
occurs as early as five days of disuse and that extreme
inactivity such as in-bed rest is often a component of critical
illness it would be worthwhile to examine how long it takes
until the pre-bed-rest state of glucose tolerance is restored
when keeping a moderate exercise level after bed rest. In this
context, however, it would also be important which exercise
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level an individual was adapted to before assuming total
inactivity like bed rest [1, 2].
Another impact aside from the sedentary lifestyle on
insulin action is energy balance. Stephens et al. [10] have
shown that in normal weight, metabolically healthy, fit test
subjects when inactivity (sitting) is combined with positive
energy balance (energy surplus) insulin action is reduced
by 39%, while sitting during balanced energy intake reduces
insulin action only by 18% compared to insulin action while
being active. They concluded that “strategies to limit daily
sitting may reduce metabolic risk disease” [10]. A more
pronounced effect of lower physical activity compared to
positive energy balance is also reviewed by Mann et al. [1].
We were able to add, as a pilot experiment, glucose
tolerance measurements before, during, and after a very
complex study, nutritional countermeasures (NUC) study,
investigating the effects of potassium bicarbonate supple-
mentation during head-down tilt bed rest onmarkers of bone
resorption. In our add-on experiment we hypothesized that
four days of normal daily activity in the ward after 21 days
of experimental bed rest (BR) will not reverse BR induced
impaired glucose tolerance in sedentary subjects.
2. Material and Methods
2.1. Study Design. Seven metabolically healthy, male, seden-
tary subjects (mean age: 27.6 (SD 3.3) years, mean bodymass:
78.6 (SD 6.4) kg, mean body mass index (BMI): 24.1 (SD
1.9) kg/m2, and VO
2
max: mL/kg body mass/min: 39.5 (SD
5.4)), no first degree relatives being diabetic, were included
in the “nutrition countermeasures” (NUC) bed-rest study
at the German Aerospace Center in Cologne, Germany, in
2010. Approval for the study was obtained from the Ethical
Committee of the Aerztekammer Nordrhein, Duesseldorf,
Germany, and the study was conducted in accordance with
the Declaration of Helsinki. Volunteers gave their written
informed consent after receiving detailed information about
the study protocol and the resulting risks. Inclusion criteria
for subjects were passing medical and psychological tests.
Exclusion criteria were any history of hypertension, diabetes,
obesity, rheumatism, hyperlipidemia, hepatic disease, bone
disease, physical exercise more than four times per week,
smoking, consumption of drugs, or alcohol excess. Moreover
subjects needed to have negative results of a thrombophilia
screening panel (AT III, S-Akt, Lupus-PTT, ferritin, Factor V
Leiden, Factor IV, and Factor II) since they would be exposed
to immobilization during the study.
The study was a randomized crossover design in two
campaigns separated by 154 days (last day of the first bed-rest
campaign and the first bed-rest day of the second campaign).
The subjects were confined to the metabolic ward 7 days
before to 6 days after the respective bed-rest period. Each
campaign consisted of seven days of pre-bed-rest baseline
data collection (BDC-7 to BDC-1), 21 days of strict six-degree
head-down tilt bed rest (HDT1 to HDT21), and six days of
post-bed-rest recovery (R+0 to R+5). Reambulation occurred
in the morning of R+0 between 9.00 and 11.00 am. Subjects
also returned to the facility on R+14 for follow-up assessment.
During the bed-rest period, subjects were kept in bed for
24 h and were not allowed to elevate their head >30∘ from
the horizontal. The lying position was confirmed by constant
video monitoring. All daily activities (such as showering,
weighing, reading, and watching television) and all lavatory
activities were carried out in this position. During the non-
bed-rest phases the subjects were allowed to walk around in
the ward without performing any physical exercise. For the
whole duration of the study a study nurse made sure they
adhered to the study rules.The studywas approved by the eth-
ical committee of theAerztekammerNordrhein,Duesseldorf,
Germany, and subjects gave their informed written consent.
As mentioned in the introduction, the primary outcome
parameters of the NUC study were bone resorption markers
in 24 h urine.However, wewere able to includeOGTTs before
and during inactivity and after reassuming. These tests were
carried out in fasting state in themornings of BDC-4,HDT21,
R+5, and R+14.
2.2. Dietary Standardization. For the first campaign, subjects
were randomized to the standard nutrition group or to the
standard nutrition plus potassium bicarbonate group. In the
second campaign the subject was obligated to participate in
the other group as part of the crossover design. All subjects
received a standardized nutrition of 1.2 g protein per kg body
mass per day, 1000–1200mg calcium per day, 3.0–5.0 g potas-
sium (plus 90mmol per day in the potassium bicarbonate
group) per day, 2.1–2.3 mmol sodium per kg body mass per
day, 1000 IU vitaminD
3
per day, and 50mLwater per kg body
mass per day. The individually tailored energy intake (total
energy expenditure) was calculated by multiplying resting
metabolic rate measured by indirect calorimetry with the
Deltatrac device (Deltatrac II MBH 200 metabolic monitor,
Datex-Ohmeda) by a physical activity level of 1.4 during
the ambulatory phase (for light physical activity) and by 1.1
during bed rest and then adding 10% of total energy expen-
diture for thermogenesis. The daily diet was also constant for
fat (28–31% of total energy expenditure) and carbohydrates
(50–55% of total energy expenditure). All other nutrients
met the recommended dietary allowances [11]. The menu
composition of each experiment day of the respective study
campaigns was identical in order to avoid any impact of
variable glycemic indices on plasma glucose and insulin
concentrations. Potential renal acid load (PRAL) calculated
according to Remer and Manz [12] was −53.2mEq/d in the
first campaign and −51.9mEq/d in the second campaign.
When subjects participated in the potassium bicarbonate
group, they drank 90mmol (3× 30mmol duringmainmeals)
potassium bicarbonate as a soluble tablet dissolved in 200mL
tapwater daily during the bed-rest phase, whereas the control
group received 200mL tap water.
Power analysis for this study was based on the primary
outcome measure bone resorption marker in 24 h urine
and not the parameter of the presented data. However,
retrospective power analyses for the effect of bed rest on
glucose and insulin concentration at an alpha level of 0.05
revealed a power of 100% for both, glucose and insulin
concentrations.
The Scientific World Journal 3
2.3. Sample and Data Collection and Analyses. In the morn-
ing (7 am) on days BDC-4, HDT21, R+5 (all in-house), and
R+14 an oral glucose tolerance test (OGTT) was applied
using 75 g of glucose dissolved in 200mL tap water, while
subjects stayed in supine position. Blood was drawn from the
antecubital vein just before (0min) and 30, 90, and 120min
after glucose application for analyses of serum glucose and
insulin concentrations. These time points were chosen to
cover a 2-hour periodwith the blood volumewewere allowed
to draw. For C-reactive protein (CRP), total cholesterol, and
triglycerides blood was only drawn in fasting conditions
on days BDC-6, BDC-2, R+2, and R+5. Whole blood was
immediately centrifuged and then aliquoted. Serum aliquots
were stored at −20∘C for later analysis.
Serum glucose was analyzed by the hexokinase/glucose-
6-phosphate dehydrogenase method (Glucose HK, Roche
Diagnostics, Mannheim, Germany) using an automated ana-
lyzer (INTEGRA 400/700/800).
Serum insulin was analyzed via an insulin ECLIA (Elec-
trochemiluminescence Immunoassay) from Roche Diagnos-
tics, Mannheim, Germany, using a Roche Hitachi Modu-
lar E170 lab automate. C-reactive protein, cholesterol, and
triglyceride concentrations have been analyzed in the BDC
and the recovery period using commercial reagents from
RocheDiagnostics,Mannheim,Germany, applied on aRoche
Hitachi Modular P800 lab automate.
Areas under the serum concentration curve (AUC) of
glucose and insulin concentrations were calculated according
to the trapezoidal rule. Insulin resistance was calculated by
the homeostatic model assessment (HOMA-IR2) according
to Levy et al. [13]. Insulin sensitivity index (ISIcomposite)
was calculated according to the equation of Matsuda and
DeFronzo [14]. We also calculated hepatic insulin resistance
(HIR) by using the equations of Abdul-Ghani et al. [15].
Body mass was determined daily after emptying bladder
and before breakfast on a sensitive weight scale (Sartorius,
type DVM 5703 MP 8-1). Body composition was analyzed
by DXA (HOLOGIC Discovery A) (upgraded model of
HOLOGIC 4500W) on day BDC-5 and day R+1.
In the BDC phase of each campaign and on R+28 of
the second campaign, subjects completed a questionnaire
on habitual physical activity [16]. This physical activity
questionnaire has been validated previously [16] and assesses
occupational (e.g., time spent standing, sitting, lifting heavy
items, and so forth at work), sport-related (i.e., types of sports
played, how frequently, and how long), and leisure-time (e.g.,
extent of television viewing) physical activities. Based on the
evaluation of these questionnaires and as presented in the
publication of Belavy´ et al. [17] post-bed-rest activity was not
different from pre-bed-rest activity.
2.4. Statistics. Data on subjects’ characteristics are presented
as means ± SD and all other values as means ± SEM.The data
were analyzed using repeated measures ANOVA techniques
(SAS, Version 9.2).The case of log-normal distribution of the
datawas tested. In case of no normal distribution, logarithmic
data was used for further analyses. Differences between study
days were tested by ANOVA. Statistical significance was
defined as 𝑃 < 0.05.
3. Results
Application of potassium bicarbonate during bed rest did not
affect glucose and insulin concentrations (data not shown).
We therefore based further analyses on the respective mean
values of each subject from both bed-rest campaigns. Fasting
serum glucose and insulin concentrations were unaffected by
bed rest (Figure 1). However, both concentrations were sig-
nificantly higher in bed rest 120min after glucose application
(both: 𝑃 < 0.001) (Figure 1). On day 21 of bed rest AUC
120min
of glucose concentration was significantly increased by 28.8
(5.2)% and AUC
120min of insulin concentrations by 35.9
(10.2)% (glucose: 𝑃 < 0.001; insulin: 𝑃 = 0.02) (Figure 2).
While AUC
120min of serum insulin concentrations on R+14
returned to pre-bed-rest concentrations (𝑃 = 0.352), the
respective AUC
120min of glucose was still higher than the pre-
bed-rest concentration (𝑃 = 0.038) (Figure 2).
Insulin resistance analyzed by HOMA-IR2 was not
affected by bed rest (Table 1). However, ISIcomposite index was
significantly decreased during bed rest (𝑃 = 0.002) and
returned to pre-bed-rest concentrations on day R+14 (𝑃 =
0.955) (Table 1). HIR index did not show any effects induced
by bed rest (Table 1).
Bodymass was 1.9 (0.15) kg lower (𝑃 < 0.001) on day 21 of
bed rest compared to prebed rest (Figure 3). However, by day
R+6 the difference was decreased to 1.4 (0.15) kg (𝑃 < 0.001).
During the bed rest period fat mass increased by 1.3 (0.3) kg
(𝑃 = 0.002), whilemusclemass decreased by 2.8 (0.5) kg (𝑃 =
0.002).
As expected, CRP concentration increased during bed
rest (BDC-2: 0.64 (0.23)mg/L; R+2: 3.85 (0.23)mg/L, 𝑃 <
0.001). Triglyceride and total cholesterol concentrations,
however, decreased until day R+2 (triglycerides: 𝑃 < 0.001;
total cholesterol: 𝑃 < 0.001) (Table 2), most likely because of
changes in dietary composition in themetabolic ward period.
4. Discussion
In the presented studywe induced impaired glucose tolerance
in metabolically healthy, sedentary young male subjects
without any first degree relatives being diabetic during
experimental bed rest. We could demonstrate that when
reassuming the sedentary lifestyle after bed rest four days is
insufficient to achieve pre-bed-rest glucose tolerance. When
applying a low level of physical activity after bed rest, it
takes between five and 14 days even in healthy, nonobese,
young subjects to reverse bed-rest induced impaired glucose
tolerance. Although the AUC for glucose on day 5 in the
recovery phase showed a significant decrease compared to the
end of bed rest, the AUC for insulin still demonstrated the
compensatory effect.
Since positive energy balance also induced impaired
glucose tolerance, we tried to keep fat mass constant by
providing individually tailored energy supply. When keeping
neutral energy balance bymatching energy intake and expen-
diture and combining the crossover design with our chosen
highly standardized study conditions, this led to significantly
impaired glucose tolerance in our 7 volunteers. These results
are in line with findings from other studies although in those
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Figure 1: (a) Mean values and SEM of serum glucose concentrations following an oral glucose tolerance test during the in-house ambulatory
phase (BDC), on day 21 in head-down tilt bed rest (HDT) and after 4 (R+5, in-house) and 13 (R+14) days of recovery. ∗∗∗𝑃 < 0.001 for the
comparison of the prebed rest to bed rest. (b) Mean values of serum insulin concentrations following an oral glucose tolerance test on the
identical days and points in time as glucose concentrations were analyzed. ∗∗∗𝑃 < 0.001 for the comparison of the prebed rest to bed rest.
BDC HDT21
0
200
250
300
350
ns∗∗∗∗∗
AU
C s
er
um
 g
lu
co
se
(m
g 
∗
 h
 ∗
 d
L−
1
)
R+5 R+14
(a)
BDC HDT21
0
60
80
100
120
140
ns ∗∗
AU
C i
ns
ul
in
(m
U
 ∗
 h
 ∗
 L
−
1
)
R+5 R+14
(b)
Figure 2: (a) Area under the curve (AUC) of glucose concentrations (mean values (SEM)) after 120min following an oral glucose tolerance
test during the in-house ambulatory phase (BDC), after 20 days (day 21) in head-down tilt bed rest (HDT) and after 4 (R+5, in-house) and
13 (R+14) days of recovery. NS: not significant. ∗𝑃 < 0.05; ∗∗𝑃 < 0.01. (b) Mean values and SEM of the AUC of serum insulin concentrations
(mean values (SEM)) after 120min following an oral glucose tolerance test on the identical days as glucose concentration was analyzed. NS:
not significant. ∗𝑃 < 0.05; ∗∗𝑃 < 0.01; ∗∗∗𝑃 < 0.001.
Table 1: Mean values (SEM) of insulin resistance and insulin sensitivity indices.
Day BDC-4 HDT21 R+5 R+14 𝑃 value
HOMA IR2 0.86 ( 0.08) 0.88 (0.08) 0.94 (0.09) 0.89 (0.16) 0.790
ISI composite 7.66 ( 1.13) 5.49 (0.60) 6.22 (0.70) 7.59 (0.84) 0.005
HIR 933 (172) 1134 (200) 1236 (250) 933 (151) 0.125
HOMA-IR: homeostatic model assessment-insulin resistance; ISI: insulin sensitivity index [14]; HIR: hepatic insulin resistance index [15].
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Table 2: Mean values of C-reactive protein, triglycerides, and total cholesterol.
Day BDC-6 BDC-2 R+2 R+5 𝑃 value
C-reactive protein (mg/L) 0.89 (0.23) 0.64 (0.23) 3.85 (0.23)∗ 1.20 (0.23) <0.001
Triglycerides (mmol/L) 1.41 (0.10) 1.38 (0.10) 1.12 (0.10)∗ 1.21 (0.10) <0.001
Total cholesterol (mmol/L) 5.21 (0.05) 4.78 (0.05) 3.89 (0.05)∗ 4.23 (0.05) <0.001
∗Value is significantly (𝑃 < 0.001) different from that one on day BDC-2.
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Figure 3: (a) Mean values and SEM of daily body mass data during the entire in-house phase and on day R+14. The vertical lines after day
1 and day R+0 represent the period of HDT bed rest. Body mass decreased significantly during the bed-rest period (𝑃 < 0.001). (b) Mean
values and SD of fat and muscle mass analyzed by DXA 5 days before HDT bed rest and on the first recovery day. ∗∗𝑃 < 0.01.
more subjects were needed to clearly show this effect [4, 18–
21]. In contrast to several other studies, in our study HOMA-
IRwas not affected while ISIcomposite demonstrated significant
decreases. HOMA-IR seems to be more influenced by fasting
glucose concentrations. Based on experiments by Tripathy
et al., it seems that when fasting glucose is only minimally
elevated HOMA-IR reflects rather hepatic than peripheral
insulin sensitivity [22]. The data would then be in line with
HIR and might explain why in the presented bed-rest study
we saw a decrease in ISIcomposite derived from an OGTT but
not in HOMA-IR.
One might argue that bed-rest induced increases in fat
mass of about 1.3 kg with concomitant decrease in lean body
mass (ca. 2.8 kg) might have induced a decrease in insulin
sensitivity. We have previously shown [23] that in bed rest
volunteers with more pronounced positive energy balance
(fat mass increase >1.8 kg) show higher markers of systematic
inflammation. This in turn could result in reduced insulin
sensitivity. Since six of our seven test subjects had lower fat
mass increase than 1.8 kg we feel that—although we should
consider it as one cause to increase CRP concentration and
in turn reduce insulin sensitivity—this may not be the main
cause for the observed effects on insulin sensitivity during
bed rest.
After bed rest the subjects got back to ambulatory
conditions meaning they were allowed to follow a light
physical activity schedule. After the in-house phase, the
subjects continued their day-by-day activity, which, as shown
by Belavy´ et al. [17] in the same group, did not differ from
pre-bed-rest activity level. However, after a phase of almost
enforced inactivity for three weeks, it may take up to two
weeks to get back to pre-bed-rest glucose tolerance. These
observations are supported by gene expression studies during
bed rest carried out byAlibegovic et al. [20]. About 80%of the
genes they tested were downregulated and 21% upregulated
and of the transcriptional changes they tested only a part
was normalized after 4 weeks of retraining. They found
changed gene expressions of several insulin resistance and
diabetes candidate genes following 9 days of bed rest in
their group of similar VO
2
max as our volunteers. After
a four-week retraining period of endurance exercise being
cycle ergometry (30min/day, 6 days/week on 70% of subjects
VO
2
max) a lack of complete normalization of these genes
still existed, even though the training led to increased VO
2
max levels in the volunteers suggesting a more intensified
training regime than their usual pre-bed-rest activity level.
Hence, although the exercise level was increased, still the gene
expression pattern did not revert to the status observed prior
to the bed-rest treatment. It might be speculated whether
resistive exercise following bed rest would be more effective.
Recent evidence has emerged to suggest that even a single
bout of resistive exercise improves insulin sensitivity [24–27].
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However, further studies are urgently needed to show which
kind and intensity of exercise might be able to counteract
inactivity induced insulin resistance in healthy subjects.
Our pilot study does have some limitations. Since the
primary outcome parameter was the effects of bed rest and
potassium bicarbonate supplementation on bone turnover
markers, it was not powered to study the post-bed-rest effects
on insulin sensitivity, although calculation of post hoc power
revealed 100% power for our results in our 7 test subjects.
We were not allowed to draw blood according to a usu-
ally foreseen schedule when analyzing insulin sensitivity by
ISIcomposite. Additionally, no further blood samples or tissue
sampling was possible to get further insight into potential
mechanisms leading to bed-rest induced insulin resistance.
In summary, our data suggest that it takes between 5 and
14 days for sedentary healthy test subjects to recover from
impaired glucose tolerance because of inactivity.When trans-
lating these results into clinical conditions where patients
usually suffer from comorbidities, further research is urgently
mandatory to evaluate a minimum training regime to avoid
glucose intolerance merely because of bed-rest induced inac-
tivity.
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